Producing Mouse Genetic Models for Human Diseases

  • J. David McDonald


The scientific literature is replete with examples of the contribution of laboratory animal models to biomedical research. Indeed, they have been invaluable to the basic research support of fields as wide-ranging as immunology, reproduction, oncology, nutrition, infectious diseases, transplantation, cardiology, and anesthesiology (Report of the Council on Scientific Affairs, 1989). Due to recent advances in the techniques required for somatic gene transfer and in the ability to produce desired models for human heritable diseases, the stage is now set to extend the range of these areas of biomedical impact to include somatic gene therapy.


Cystic Fibrosis Embryonic Stem Cell Mouse Embryonic Stem Cell Cystic Fibrosis Transmembrane Regulator Single Base Change 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Batzer MA, Tedeschi B, Fossett NG, Tucker, Kilroy G, Arbour P, Lee WR (1988): Spectra of molecular changes induced in DNA of Drosophila spermatozoa by 1-ethyl-1-nitrosourea and x-rays. Mutat Res 199: 255–268PubMedCrossRefGoogle Scholar
  2. Bode VC, McDonald JD, Guenet J, Simon D (1988): hph-1: A mouse mutant with hereditary hyperphenylalaninemia induced by ethylnitrosourea mutagenesis. Genetics 118: 299–305PubMedGoogle Scholar
  3. Bulfield G (1981): Inborn errors of metabolism in the mouse. In: Biology of the House Mouse. Berry RJ, Ed. New York: Academic PressGoogle Scholar
  4. Capecchi M (1989): The new mouse genetics: Altering the genome by gene targeting. Trends Genet 5: 70–76PubMedCrossRefGoogle Scholar
  5. Chapman VM, Miller DR, Armstrong D, Caskey CT (1989): Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci USA 86: 1292–1296PubMedCrossRefGoogle Scholar
  6. Chisaka O, Capecchi MR (1991): Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene Hox-1.5. Nature 350: 473–479PubMedCrossRefGoogle Scholar
  7. Chisaka O, Muisu TS, Capecchi MR (1992): Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6. Nature 355: 516–520PubMedCrossRefGoogle Scholar
  8. Colledge WH, Rateliff R, Foster D, Williamson R, Evans MJ (1992): Cystic fibrosis mouse with intestinal obstruction. Lancet 340: 680PubMedCrossRefGoogle Scholar
  9. Cotton RGH, Rodrigues NR, Campbell RD (1988): Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations. Proc Natl Acad Sci USA 85: 4397–4401PubMedCrossRefGoogle Scholar
  10. Darling SM, Abbott CM (1992): Mouse models of human single gene disorders I: Non-transgenic mice. Bio Essays 14: 359–365Google Scholar
  11. Davis AC, Wims M, Bradley A (1992): Investigation of coelectroporation as a method for introducing mutations into embryonic stem cells. Mol Cell Biol 12: 2769–2776PubMedGoogle Scholar
  12. Davisson MT, Lalley PA, Peters J, Doolittle DP, Hillyard AL, Searle, AG (1991): Report of the comparative committee for human, mouse and other rodents. Cytogenet Cell Genet 58: 1152–1189CrossRefGoogle Scholar
  13. Dietrich W, Katz H, Lincoln SE (1992): A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131: 423–447PubMedGoogle Scholar
  14. Doetschman T, Gregg RG, Maeda N, Hooper ML, Melton DW, Thompson S, Smithies O (1987): Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330: 576–578PubMedCrossRefGoogle Scholar
  15. Doetschman T, Maeda N, Smithies O (1988): Targeted mutation of the HPRT gene in mouse embryonic stem cells. Proc Natl Acad Sci USA 85: 8583–8587PubMedCrossRefGoogle Scholar
  16. Donehower LA, Harvey M, Slagle BL (1992): Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215–221PubMedCrossRefGoogle Scholar
  17. Dorin JR, Dickinson P, Alton EWFW, Smith SN, Geddes OM, Stevenson BJ, Kimber WL, Fleming S, Clarke AR, Hooper ML, Anderson L, Beddington RSP, Proteous DJ (1992): Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 359: 211–215PubMedCrossRefGoogle Scholar
  18. Eckert KA, Ingle CA, Klinedirst DK, Drinkwater NR (1988): Molecular analysis of mutations induced in humans cells by N-ethyl-N-nitrosourea. Mol Carcinogen 1: 50CrossRefGoogle Scholar
  19. Erickson RP (1989): Why isn’t a mouse more like a man? Trends Genet 5:1-3PubMedCrossRefGoogle Scholar
  20. Evans MJ, Kaufman MH (1981): Establishment of pluripotential cells from mouse embryos. Nature 292: 154–156PubMedCrossRefGoogle Scholar
  21. Gossler A, Doetschman T, Korn R, Serfling E, Kemler R (1986): Transgenesis by means of blastocyst-derived embryonic stem cell lines. Proc Natl Acad Sci USA 83: 9065–9069PubMedCrossRefGoogle Scholar
  22. Harding CO, Williams P, Pflanzer DM, Colwell RE, Lyne PW, Wolff JA (1992): sar: A genetic mouse model for human sarcosinemia generated by ethylnitrosourea mutagenesis Proc Natl Acad Sci USA 89: 2644–2648PubMedCrossRefGoogle Scholar
  23. Hasty P, Ramirez-Soliz R, Krumlauf R (1991a): Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350: 243–246PubMedCrossRefGoogle Scholar
  24. Hasty P, Rivera-Perez J, Bradley A (1991b): The length of homology required for gene targeting in embryonic stem cells. Mol Cell Biol 11: 5586–5591PubMedGoogle Scholar
  25. Hasty P, Rivera-Perez J, Chang C, Bradley A (1991c): Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol Cell Biol 11: 4509–17PubMedGoogle Scholar
  26. Hasty P, Rivera-Perez J, Bradley A (1992): The role and fate of DNA ends for homologous recombination in embryonic stem cells. Mol Cell Biol 12: 2462–2474Google Scholar
  27. Hitotsumachi S, Carpenter D, Russell WL (1983): Dose fractionation as a means of increasing the mutagenic effectiveness of ethylnitrosourea in mouse spermatogonia. Environ Mutagen 5: 380–385Google Scholar
  28. Hogan B, Constantini F, Lacy E (1986): Manipulating the Mouse Embryo. New York: Cold Spring Harbor Laboratory PressGoogle Scholar
  29. Hooper M, Hardy K, Handyside A, Hunter S, Monk M (1987): HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326: 292–295PubMedCrossRefGoogle Scholar
  30. Jasin M, Berg P (1988): Homologous integration in mammalian cells without target gene selection. Genes Dev 2: 1353–1363PubMedCrossRefGoogle Scholar
  31. Jeannotte L, Ruiz JC, Robertson EJ (1991): Low level of Hox-1.3 gene expression does not preclude the use of promoterless vectors to generate a targeted gene disruption. Mol Cell Biol 11: 5578–5585PubMedGoogle Scholar
  32. Johnson RS, Sheng M, Greenberg ME, Kolodner RD, Papaioannou VE (1989): Targeting of nonexpressed genes in embryonic stem cells via homologous recombination. Science 245: 1234–1236PubMedCrossRefGoogle Scholar
  33. Joyner AL, Skarnes WC, Rossant J (1989): Production of a mutation in mouse En- 2 gene by homologous recombination in embryonic stem cells. Nature 338: 153–156PubMedCrossRefGoogle Scholar
  34. Kim H, Smithies O (1988): Recombinant fragment assay for gene targeting based on the polymerase chain reaction. Nucleic Acids Research 16: 8887–8903PubMedCrossRefGoogle Scholar
  35. Kitamura D, Roes J, Kiihn R, Rajewsky K (1991): A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin chain gene. Nature 350: 423–426PubMedCrossRefGoogle Scholar
  36. Koller BH, Smithies O (1989): Inactivating the 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 86: 8932–8935PubMedCrossRefGoogle Scholar
  37. Koller BH, Hageman LJ, Doetschman T, Hageman JR, Huang S, Williams PJ, First NL, Maeda N, Smithies O (1989): Germline transmission of a planned alteration made in a hypoxanthine phosphoribosyl transferase gene by ho-mologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 86: 8927–8931PubMedCrossRefGoogle Scholar
  38. Koller BH, Kim H, Latour AM, Brigman K, Boucher RC, Scambler P, Wainwright B, Smithies O (1991): Toward an animal model of cystic fibrosis: Targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc Natl Acad Sci USA 88: 10730–10734PubMedCrossRefGoogle Scholar
  39. Koller BH, Smithies O (1992): Altering genes in animals by gene targeting. Annu Rev Immunol 10: 705–730PubMedCrossRefGoogle Scholar
  40. Kuehn MR, Bradley A, Robertson EJ, Evans MJ (1987): A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326: 295–298PubMedCrossRefGoogle Scholar
  41. Le Mouellic H, Lallemand Y, Brulet P (1992): Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell 69: 251–264PubMedCrossRefGoogle Scholar
  42. Lee CS, Curtis D, McCarron M, Love C, Gray M, Bender W, Chovnick A (1987): Mutations affecting expression of the rosy locus in Drosophilia melanogaster. Genetics 116: 55–66PubMedGoogle Scholar
  43. Leiter EH, Beamer WG, Shultz LD, Barker JE, Lane PW (1987): Mouse models of genetic diseases. In: Medical and Experimental Mammalian Genetics: A Perspective. McKusick VA, Roderick TH, Mori J, Paul NW, eds. New York: LissGoogle Scholar
  44. Lewis SG, Erickson RP, Barnett LB, Venta PJ, Tasian RE (1988): N-ethyl-N-nitrosourea-induced null mutation at the mouse Car-2 locus: An animal model for human carbonic anhydrase II deficiency syndrome. Proc Natl Acad Sci USA 85: 1962–1966Google Scholar
  45. Lufkin T, Dierich A, LeMeur M, Chambion P (1991): Disruption of the Hox-1.6 homeobox gene results in defects in a region corresponding to its rostral domain of expression. Cell 66: 1105–1119PubMedCrossRefGoogle Scholar
  46. Mansour SL, Thomas KR, Capecchi MR (1988): Disruption of the proto-oncogene int-2 in mouse-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336: 348–352PubMedCrossRefGoogle Scholar
  47. Martin G (1981): Isolation of a pluripotential cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78: 7634–7638PubMedCrossRefGoogle Scholar
  48. McDonald JD, Bode VC, Dove WF, Shedlovsky A (1990): Pahhph -5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA 87: 1965–1967PubMedCrossRefGoogle Scholar
  49. McKusick VA, Francomano CA, Antonarakis SE (1992): Mendelian inheritance in man: catalogs of autosomal dominant, autosomal recessive, and X-linked phenotypes, 10th edition. Baltimore, Johns Hopkins University PressGoogle Scholar
  50. Merkle S, Pretsch W (1989): Characterization of triosephosphate isomerase mutants with reduced enzyme activity in Mus musculus. Genetics 123: 837–844PubMedGoogle Scholar
  51. Metsaranta M, Vuorio E (1992): Transgenic mice as models for heritable diseases. Ann Med 24: 117–120PubMedCrossRefGoogle Scholar
  52. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE (1992): RAG-1-deficient mice have no mature B, T lymphocytes. Cell 68: 869–877PubMedCrossRefGoogle Scholar
  53. Moser A R, Pitot H C, Dove W F (1990): A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247: 322–324PubMedCrossRefGoogle Scholar
  54. O’Brien SJ ed (1992): Genetic maps: locus maps of complex genomes, 6th edition. New York, Cold Spring Harbor Laboratory PressGoogle Scholar
  55. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989): Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874–879PubMedCrossRefGoogle Scholar
  56. Pastink AC, Vrecken C, Vogel EW (1988): The Nature of W-ethyl-N- ethylnitrosourea-induced mutations at the white locus of Drosophila melanogaster. Mutat Res 199: 47–53PubMedCrossRefGoogle Scholar
  57. Pastink AC, Vreeken C, Mivard MJM, Searles LL, Vogel EW (1989): Sequence analysis of N-ethyl-N-nitrosourea-induced Vermilion mutations in Drosophila melanogaster. Genetics 123: 123–129PubMedGoogle Scholar
  58. Peters J, Andrews SJ, Loutit JF, Clegg JB (1985): A mouse-globin mutant that is an exact model of hemoglobin Ranier in man. Genetics 110: 709–721PubMedGoogle Scholar
  59. Peters J, Jones J, Ball ST, Clegg JB (1990): Analysis of electrophoretically detected mutations induced in mouse germ cells by ethylnitrosourea. In: Biology of Mammalian Germ Cell Mutagenesis, Allen JW, Bridges B A, Lyon MF, Moses MJ, Russell LB, eds. New York, Cold Spring Harbor Laboratory PressGoogle Scholar
  60. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992): Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89: 4471 - 4475Google Scholar
  61. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL (1992): Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343–353PubMedCrossRefGoogle Scholar
  62. Popp RA, Bailiff EG, Skow LC, Johnson FM, Lewis SE (1983): Analysis of a mouse-globin gene mutation induced by ethylnitrosourea. Genetics 105: 157–167PubMedGoogle Scholar
  63. Pretsch W, Charles DJ, Merkle S (1988): X-linked glucose-6-phosphate dehydrogenase deficiency in Mus musculus. Biochem Genet 26: 89–103PubMedCrossRefGoogle Scholar
  64. Reid LH, Shesely EG, Kim HS, Smithies O (1991): Cotransformation and gene targeting in mouse embryonic stem cells. Mol Cell Biol 11: 2769–2777PubMedGoogle Scholar
  65. Report of the Council on Scientific Affairs (1989): Animals in Research. JAMA 261 (24): 3602–3606Google Scholar
  66. Richardson KK, Richardson FC, Crosby RM, Swenberg JA, Skopek TR (1987): DNA base changes and alkylation following in vivo exposure of Escherichia coli to N-ethyl-AT-nitrosourea. Proc Natl Acad Sci USA 84: 344–348PubMedCrossRefGoogle Scholar
  67. Robertson EJ, Bradley A, Kuehn M, Evans M (1986): Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Nature 323: 445–447PubMedCrossRefGoogle Scholar
  68. Robertson EJ (1991): Using embryonic stem cells to introduce mutations into the mouse germline. Biol Reprod 44: 238–245PubMedCrossRefGoogle Scholar
  69. Russell WL, Kelly EM, Hunsicker PR, Bangham JW, Maddux SC, Phipps EL (1979): Specific locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci USA 76: 5818–5819PubMedCrossRefGoogle Scholar
  70. Russell WL, Hunsicker PR, Raymer GD, Steele MH, Stelzner KF, Thompson HM (1982a): Dose response for ethylnitrosourea-induced-specific-locus mutations in mouse spermatogonia. Proc Natl Acad Sci USA 79: 3589–3591PubMedCrossRefGoogle Scholar
  71. Russell WL, Hunsicker PR, Carpenter DA, Cornett CV, Guinn GM (1982b): Effect of dose fractionation on the ethylnitrosourea induction of specific-locus mutations in mouse spermatogonia. Proc Natl Acad Sci USA 79: 3592–3593PubMedCrossRefGoogle Scholar
  72. Schwartzberg PL, Goff SP, Robertson EJ (1989): Germline transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246: 799–803PubMedCrossRefGoogle Scholar
  73. Shedlovsky A, McDonald JD, Symula D, Dove WF (1992): Mouse models of human PKU. Submitted to Genetics Google Scholar
  74. Smithies O (1993): Animal models of human genetic diseases. Trends Genet (In Press)Google Scholar
  75. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O, Koller BH (1992): An animal model for cystic fibrosis made by gene targeting. Science 257: 1083–1088PubMedCrossRefGoogle Scholar
  76. Soriano P, Montgomery C, Geske R, Bradley A (1991): Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice. Cell 64: 693–702PubMedCrossRefGoogle Scholar
  77. Su L, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF (1992): Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668–670PubMedCrossRefGoogle Scholar
  78. te Riele H, Maandag ER, Berns A (1992): Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc Natl Acad Sci USA 89: 5128–5132CrossRefGoogle Scholar
  79. Thomas KR, Deng C, Capecchi MR (1992): High-fidelity gene targeting in embryonic stem cells by using sequence replacement vectors. Mol Cell Biol 12: 2919–2923PubMedGoogle Scholar
  80. Thomas KR, Capecchi MR (1987): Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503PubMedCrossRefGoogle Scholar
  81. Thompson S, Clarke AR, Pow AM, Hooper ML, Melton DW (1989): Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56: 313–321PubMedCrossRefGoogle Scholar
  82. Tybulewics VLJ, Tremblay ML, LeMarca ME, Willemsen R, Stubblefield BK, Winfield S, Zablorka B, Sidransky E, Martin BM, Huang SP, Mintzer KA, Westphal H, Mulligan RC, Ginns EI (1992): Animal model of Gaucher’s disease from targeted disruption of the mouse glucocerebrosidase gene. Nature 357: 407–410CrossRefGoogle Scholar
  83. Valancius V, Smithies O (1991a): Double-strand gap repair in a mammalian gene targeting reaction. Mol Cell Biol 11: 4389–4397PubMedGoogle Scholar
  84. Valancius V, Smithies O (1991b): Testing and “in-out” targeting procedure for making subtle modifications in mouse embryonic stem cells. Mol Cell Biol 11: 1402–1408PubMedGoogle Scholar
  85. Vogel E, Natarjan AJ (1979): The relation between reaction kinetics and mutagenic action of mono-functional alkylating agents in higher eukaryotic systems. I Recessive lethal mutations and translocations in Drosophila. Mutation Res 62: 51–100PubMedCrossRefGoogle Scholar
  86. Williams Rl, Hilton DJ, Pease S, Willson TA, Stewart CL, Gearing DP, Wagner EF, Metcalf D, Nicola NA, Gough NM (1988): Myeloid leukemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336: 684–687PubMedCrossRefGoogle Scholar
  87. Zeilenska M, Beranek D, Guttenplan JB (1988): Different mutational profiles induced by N-nitroso-N-ethylurea: Effects of dose and error-prone DNA repair and correlations with DNA adducts Environ Molec Mutagen 11: 473–485CrossRefGoogle Scholar
  88. Zhang SH, Reddick RL, Piedrahita JA, Maeda N (1992): Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468–471Google Scholar
  89. Zheng H, Hasty P, Brenneman MA, Grompe M, Gibbs RA, Wison JH, Bradley A (1991): Fidelity of targeted recombination in human fibroblasts and murine embryonic stem cells. Proc Natl Acad Sci USA 88: 8067–8071PubMedCrossRefGoogle Scholar
  90. Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R (1989): Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature 342: 435–438PubMedCrossRefGoogle Scholar
  91. Zimmer A, Grass P (1989): Production of chimeric mice containing embryonic stem (ES): cells carrying a mutation of homoeobox Hox 1.1 allele mutated by homologous recombination Nature 338: 150–153PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Boston 1994

Authors and Affiliations

  • J. David McDonald

There are no affiliations available

Personalised recommendations